← Browse by Condition
Medical Condition

kidney tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07053462 Phase 1, Phase 2
Recruiting

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Enrollment
90 pts
Location
China
Sponsor
AMERICAN ORGAN TRANSPLANT AND ...
View Trial →